Topic: Specialty Drugs

  • Mortgaging New Treatments Kicks the Can on High Drug Prices

  • A $475,000 price tag for a new cancer drug: crazy or meh?

  • Prevalence of Off-Label Use and Spending Among Patent-Protected Chemotherapies

  • Abandon Biosimilars as Biologics are Natural Monopolies

  • Overview of Original Subscription Model and Features of LA and WA Proposals

    Overview of Original Subscription Model and Features of LA and WA Proposals

  • The “Netflix Model” of Financing Hepatitis C Treatment

    The “Netflix Model” of Financing Hepatitis C Treatment

  • Perspective on National Coverage Analysis of CAR-T Therapies

    Perspective on National Coverage Analysis of CAR-T Therapies

  • R&D Costs Do Not Explain Elevated U.S. Drug Prices

  • The U.S. Government Should Buy Gilead for $156Bn to Save Money on Hep C

  • Hospital Outpatient versus Doctor Office Cost for Physician Administered Cancer Drugs

    Hospital Outpatient versus Doctor Office Cost for Physician Administered Cancer Drugs